Delivery Order SPE2DE24DA017-SPE2D626F58T3
- Not listed
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical devices headquartered in Naples, Florida, was awarded a delivery order valued at $2,201.10 by the Defense Logistics Agency's Medical Supply Chain on December 19, 2025. The delivery order is for suture anchors in a bio-composite material with dimensions of 2.9 x 12.5mm. This award operates under Arthrex's larger indefinite delivery contract SPE2DE24D0020 with the Defense Logistics Agency, a comprehensive master...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain valued at $25,656.70 for suture anchors (1.8mm, 2-pack). Issued on August 18, 2025, with an ultimate completion date of September 2, 2025, this fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal marketplace....
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a $4,624.00 delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for suture anchors (1.8mm, 2-pack, 1 set). This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 17, 2025, and will be performed in Naples, Florida. The award represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order award valued at $3,274.20 from the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The contract calls for delivery of DX Fibertak Suture Anchor, #2 MTS with needle, with an ultimate completion date of September 11, 2025. This fixed-price delivery order with economic price adjustment was awarded without set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,135.00 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025. The delivery order, classified as fixed price with economic price adjustment, calls for suture anchors with corkscrew feet measuring 3.5x10mm and is scheduled for completion by September 19, 2025. This award was made without a set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $21,825.77 for suture anchors, bio-composite P-lock, 2.9 x 12.5mm. The award, issued on May 5, 2025, with an ultimate completion date of May 8, 2025, represents a fixed-price contract with economic price adjustment under the Defense Logistics Agency's Medical Supply Chain. This delivery order carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, has been awarded a delivery order valued at $15,634.25 for suture anchors (bio-composite, 2.9 x 12.5mm) by the Defense Logistics Agency's Medical Supply Chain. The award, issued on October 22, 2025, with an ultimate completion date of October 27, 2025, utilizes a fixed-price contract with economic price adjustment terms and carries no set-aside designation. This delivery order is executed under...
- Arthrex Inc., a leading minimally invasive orthopedic medical technology company headquartered in Naples, Florida, was awarded a delivery order valued at $4,402.20 by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025. The delivery order, which covers a suture anchor bio-composite product (2.9 x 12.5mm), is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of September 17, 2025. This award does not...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $4,815.36 on September 12, 2025, for biocomposite pushlock suture anchors. This fixed-price contract with economic price adjustment provisions is scheduled for completion by September 17, 2025, and will be performed in Naples, Florida. The award represents a task order issued under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $2,366.10 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for suture anchors (bio-composite, 2.9 x 12.5mm). The delivery order, which is not set aside for any specific business type, is expected to be completed by July 29, 2025, and will be performed in Naples, FL. This award represents a task order issued under Arthrex's larger...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F58T3Delivery Order
Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a delivery order award valued at $2,201.10 from the Defense Logistics Agency's Medical Supply Chain on December 28, 2025, for suture anchors with biocomposite specifications (2.9 x 12.5mm). The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of January 12, 2026. This award was issued without set-aside designation, reflecting Arthrex's established competitive position as a prime contractor supplying advanced orthopedic solutions to federal healthcare systems. The place of performance is designated as Naples, FL 34108, representing Arthrex's primary manufacturing and distribution location. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, a single-award master contract vehicle valued at approximately $471 million and effective through September 1, 2029. The IDC authorizes procurement of a comprehensive orthopedic product portfolio including surgical implants, arthroscopic instruments, and biologics supporting Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. As a Subchapter S Corporation operating as prime contractor with no identified subcontractors, Arthrex provides direct fulfillment of federal orthopedic surgical requirements across multiple specialty areas, with this suture anchor delivery supporting the broader federal commitment to advanced surgical capabilities for military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/27/25 |